Pharmaceutical

Precision Medicine Market is predictable to reach a valuation of USD 126.14 Billion by 2025 growing at a 12.48% CAGR from 2019 to 2025, Among all disease categories, recent advances in cancer care have been closely associated with genomic medicine. Understanding the genetic mutations of individual tumors holds the promise of giving physicians a higher capacity to prescribe specific medication to fight specific tumors types. However, there are only a few tumors and tumor types that have been associated with specific genetic mutations